- Home
- AMOD vs OSRH Comparison
AMOD vs OSRH Comparison
Compare AMOD & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMOD
- OSRH
- Stock Information
- Founded
- AMOD 2014
- OSRH N/A
- Country
- AMOD United States
- OSRH United States
- Employees
- AMOD N/A
- OSRH N/A
- Industry
- AMOD
- OSRH
- Sector
- AMOD
- OSRH
- Exchange
- AMOD NYSE
- OSRH Nasdaq
- Market Cap
- AMOD 18.7M
- OSRH 19.0M
- IPO Year
- AMOD N/A
- OSRH N/A
- Fundamental
- Price
- AMOD $1.39
- OSRH $0.98
- Analyst Decision
- AMOD
- OSRH
- Analyst Count
- AMOD 0
- OSRH 0
- Target Price
- AMOD N/A
- OSRH N/A
- AVG Volume (30 Days)
- AMOD 7.4M
- OSRH 927.3K
- Earning Date
- AMOD 08-15-2025
- OSRH 08-24-2025
- Dividend Yield
- AMOD N/A
- OSRH N/A
- EPS Growth
- AMOD N/A
- OSRH N/A
- EPS
- AMOD 0.12
- OSRH N/A
- Revenue
- AMOD N/A
- OSRH N/A
- Revenue This Year
- AMOD N/A
- OSRH N/A
- Revenue Next Year
- AMOD N/A
- OSRH N/A
- P/E Ratio
- AMOD $11.70
- OSRH N/A
- Revenue Growth
- AMOD N/A
- OSRH N/A
- 52 Week Low
- AMOD $1.01
- OSRH $0.90
- 52 Week High
- AMOD $13.49
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- AMOD N/A
- OSRH N/A
- Support Level
- AMOD N/A
- OSRH N/A
- Resistance Level
- AMOD N/A
- OSRH N/A
- Average True Range (ATR)
- AMOD 0.00
- OSRH 0.00
- MACD
- AMOD 0.00
- OSRH 0.00
- Stochastic Oscillator
- AMOD 0.00
- OSRH 0.00
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.